164 related articles for article (PubMed ID: 24849430)
1. [Detection of fetal chromosomal aneuploidy in pregnant women at advanced maternal age during the first trimester].
Wang S; Gao Z; Lu Y; Li Y; Jiang S; Wang L; Zhang L
Nan Fang Yi Ke Da Xue Xue Bao; 2014 May; 34(5):655-8. PubMed ID: 24849430
[TBL] [Abstract][Full Text] [Related]
2. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
[TBL] [Abstract][Full Text] [Related]
3. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
[TBL] [Abstract][Full Text] [Related]
4. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
5. [Karyotype analysis of amniotic fluid cells and comparison of chromosomal abnormality rate during second trimester].
Zhang YP; Wu JP; Li XT; Lei CX; Xu JZ; Yin M
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):644-8. PubMed ID: 22176986
[TBL] [Abstract][Full Text] [Related]
6. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
Chen X; Chang Y; Cui HY; Ren CC; Yu BY
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
[TBL] [Abstract][Full Text] [Related]
7. Fetal karyotyping after 28 weeks of gestation for late ultrasound findings in a low risk population.
Drummond CL; Gomes DM; Senat MV; Audibert F; Dorion A; Ville Y
Prenat Diagn; 2003 Dec; 23(13):1068-72. PubMed ID: 14691994
[TBL] [Abstract][Full Text] [Related]
8. The Diagnosis Pattern of Mid-Trimester Fetal Chromosomal Aneuploidy in Xuzhou and the Clinical Applications.
Fang Y; Wang G; Wang C; Suo F; Gu M; Xia Y
Cell Biochem Biophys; 2015 Nov; 73(2):267-270. PubMed ID: 25733332
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of non-invasive prenatal screening detection in fetal chromosome aneuploidy].
Cai AJ; Zhu CF; Xue SW; Cui SY; Qu SZ; Liu N; Kong XD
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):765-769. PubMed ID: 29179272
[No Abstract] [Full Text] [Related]
10. [Application of next-generation DNA sequencing for prenatal testing of fetal chromosomal aneuploidies].
Liu J; Wang H; Xi H; Jia Z; Zhou Y; Wu L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Aug; 32(4):533-7. PubMed ID: 26252102
[TBL] [Abstract][Full Text] [Related]
11. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
Audibert F; Gagnon A; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
[TBL] [Abstract][Full Text] [Related]
12. [Rapid detection of the most common chromosomal aneuploidies in the second-trimester amniotic fluid using QF-PCR].
Švecová I; Burjanivová T; Kršiaková J; Lasabová Z; Biringer K; Kapustová I; Móricová P; Danko J
Ceska Gynekol; 2013 Aug; 78(4):373-8. PubMed ID: 24040987
[TBL] [Abstract][Full Text] [Related]
13. A Method to Quantify Cell-Free Fetal DNA Fraction in Maternal Plasma Using Next Generation Sequencing: Its Application in Non-Invasive Prenatal Chromosomal Aneuploidy Detection.
Xu XP; Gan HY; Li FX; Tian Q; Zhang J; Liang RL; Li M; Yang XX; Wu YS
PLoS One; 2016; 11(1):e0146997. PubMed ID: 26765738
[TBL] [Abstract][Full Text] [Related]
14. [Performance of different methods of estimating risk screening for chromosomal anomalies].
Avătăjitei MC; Moscalu M; Martiniuc V; Onofriescu M
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):515-22. PubMed ID: 23077946
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of noninvasive prenatal testing for common fetal aneuploidies in an early gestational window.
Shi X; Zhang Z; Cram DS; Liu C
Clin Chim Acta; 2015 Jan; 439():24-8. PubMed ID: 25286007
[TBL] [Abstract][Full Text] [Related]
16. Efficiency of non-invasive prenatal screening in pregnant women at advanced maternal age.
Zhu H; Jin X; Xu Y; Zhang W; Liu X; Jin J; Qian Y; Dong M
BMC Pregnancy Childbirth; 2021 Jan; 21(1):86. PubMed ID: 33499806
[TBL] [Abstract][Full Text] [Related]
17. First-trimester risk assessment based on ultrasound and cell-free DNA vs combined screening: a randomized controlled trial.
Kagan KO; Sroka F; Sonek J; Abele H; Lüthgens K; Schmid M; Wagner P; Brucker S; Wallwiener D; Hoopmann M
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):437-444. PubMed ID: 28925570
[TBL] [Abstract][Full Text] [Related]
18. [Detection of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening of fetal chromosomal aneuploidies in women of advanced maternal age].
Zhu H; Miao Z; Qian Y; Li H; Jin J; He J; Dong M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 May; 46(3):256-261. PubMed ID: 29039166
[TBL] [Abstract][Full Text] [Related]
19. The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort.
Li SW; Barrett AN; Gole L; Tan WC; Biswas A; Tan HK; Choolani M
Singapore Med J; 2015 Jan; 56(1):47-52. PubMed ID: 25640099
[TBL] [Abstract][Full Text] [Related]
20. [Prenatal chromosome analysis using the FISH technique allows fetal aneuploidy detection within a few hours].
Steinborn A; Röddiger S; Born HJ; Baier P; Halberstadt E
Z Geburtshilfe Neonatol; 1996; 200(5):186-90. PubMed ID: 9035828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
